Your Location: | Change Location
Your Location: | Change Location

Featured, Health

Human clinical trial of COVAXIN to begin at AIIMS today

The All India Institute of Medical Sciences (AIIMS) is expected to begin the human clinical trial of the indigenously-developed COVID-19 vaccine candidate from Monday.

AIIMS Ethics Committee had given its nod for the human clinical trial of COVAXIN.AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research for conducting phase I and II human trials of COVAXIN.

No tags for this post.

Leave a Reply

Your email address will not be published. Required fields are marked *


India-New Zealand Cyber Dialogue

November 29, 2017

The first India-New Zealand Cyber Dialogue was held in New Delhi on November 27, 2017. … More India-New Zealand Cyber Dialogue »